相关实验视频
Updated: Jul 7, 2025

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
代谢调节剂G6PD在人类癌症中的新兴作用
Alfar Ahamed1,2, Rendy Hosea1,2, Shourong Wu1,2,3
1Key Laboratory of Biorheological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400045, China.
International journal of molecular sciences
|December 23, 2023
概括
葡萄糖-6-酸盐脱酶 (G6PD) 通过改变细胞代谢来促进癌症的生长. 抑制G6PD在抑制瘤进展和克服药物耐药性方面表现有前途,提供了潜在的新型抗瘤疗法.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢途径 代谢途径
背景情况:
- 代谢重编程,特别是葡萄糖代谢,是癌症的一个关键标志.
- 葡萄糖-6-酸脱酶 (G6PD) 对于酸通路 (PPP) 是至关重要的,产生NADPH和核酸,对于瘤细胞生存和增殖至关重要.
- 在各种癌症中观察到高G6PD表达和PPP流量,与瘤进展和对治疗的抗性相关.
研究的目的:
- 审查G6PD的结构意义.
- 阐明G6PD在瘤发育和进展中的作用和调节.
- 探索针对G6PD的癌症治疗治疗策略.
主要方法:
- 关于癌症中G6PD结构和功能研究的文献综述.
- 分析G6PD,PPP流和癌症特征之间的相关性.
- 评估G6PD抑制剂作为潜在的抗癌药物.
主要成果:
- G6PD在维持增殖信号传递,抵抗细胞死亡,促进侵袭和转移方面发挥着重要作用.
- 抑制G6PD可以抑制瘤细胞增殖,诱导细胞死亡,逆转化疗抵抗,并抑制转移.
- 小分子G6PD抑制剂显示出潜在的抗瘤作用,无论是单一治疗还是联合治疗.
结论:
- G6PD是癌症代谢和进展的关键调节者.
- 针对G6PD代表了对各种癌症的有前途的治疗策略.
- 尽管存在诸如潜在副作用等挑战,但G6PD抑制剂的进一步开发是有必要的.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Electron Transport Chain: Complex I and II
13.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.7K

